Proximal TEmporary oCclusion using balloon guide caTheter for Mechanical Thrombectomy (PROTECT-MT): study protocol for a multicenter randomized trial
Journal of Neurointervention · 2025
DOI: 10.21037/jni-24-5 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Neurointervention, 2025. Verfasst von Yu Zhou und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Uncertainty exists over use of balloon guide catheter (BGC) for mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) due to anterior circulation large vessel occlusion (LVO). We conducted this trial to determine the efficacy and safety of BGC as compared to conventional guide catheter on functional outcome in patients with AIS and treated with thrombectomy.
Methods
Proximal TEmporary oCclusion using balloon guide caTheter for Mechanical Thrombectomy (PROTECT-M) is an investigator-initiated, multicenter, prospective, open-label trial with blinded outcome assessment assessing the effectiveness and safety of BGC versus conventional guide catheter in AIS. Adult patients with AIS within 24 h of the onset of symptoms and eligible for thrombectomy according to local guidelines would be randomized via an Internet-based randomization system in a 1:1 manner to receive either thrombectomy with BGC (intervention) or with conventional guide catheter (control). The primary outcome is an ordinal shift analysis of scores on the modified Rankin scale (mRS) at 90 days. A sample size of 1,074 subjects is estimated to provide 87% power to detect an 8% absolute increment in good outcome from BGC using ordinal logistic regression, which also allows for 5% dropout rate and 5% crossover rate. Recruitment of the trial started on February 7, 2023. At a meeting of the independent Data and Safety Monitoring Board in November 13, 2023 to review primary outcome data available for 169 patients, they recommended suspension of recruitment due to safety concerns, which was implemented by the Trial Steering Committee with 329 randomized patients. The Trial Steering Committee stopped recruitment due to the safety concerns persisted on further review of the data for all 329 patients on April 18, 2024.
Discussion
PROTECT-MT is the largest randomized trial assessing the effectiveness of BGC versus conventional guide catheter on functional outcome in LVO patients treated with thrombectomy; it will provide further randomized evidence on the role of flow arrest using BGC in patients with AIS and treated with thrombectomy. Trial Registration: ClinicalTrials.gov, NCT05592054.
Zitieren
APA
Zhou, Y., Zhang, L., Zhang, Y., Li, Z., Xing, P., Shen, H., Zhu, X., Goyal, M., Liu, J., & Yang, P. (2025). Proximal TEmporary oCclusion using balloon guide caTheter for Mechanical Thrombectomy (PROTECT-MT): study protocol for a multicenter randomized trial. Journal of Neurointervention. https://doi.org/10.21037/jni-24-5
Vancouver
Zhou Y, Zhang L, Zhang Y, Li Z, Xing P, Shen H, et al. Proximal TEmporary oCclusion using balloon guide caTheter for Mechanical Thrombectomy (PROTECT-MT): study protocol for a multicenter randomized trial. Journal of Neurointervention. 2025. doi:10.21037/jni-24-5
BibTeX
@article{Zhou2025,
author = {Zhou, Yu and Zhang, Lei and Zhang, Yongwei and Li, Zifu and Xing, Pengfei and Shen, Hongjian and Zhu, Xuan and Goyal, Mayank and Liu, Jianmin and Yang, Pengfei},
title = {Proximal TEmporary oCclusion using balloon guide caTheter for Mechanical Thrombectomy (PROTECT-MT): study protocol for a multicenter randomized trial},
journal = {Journal of Neurointervention},
year = {2025},
doi = {10.21037/jni-24-5}
}
EUVIMED